DTIL:NASDAQ
Precision BioSciences Inc
$6.67
0.00%
(0.00) 1D
$6.64
arrow_downward
-0.44% (-0.029)bedtimeAfter hours
Closed: Sep 18, 4:00:01 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for DTIL...
Open
$6.65
High
$6.87
Low
$6.57
Mkt. cap
184.10M
Avg. vol.
263.68K
Volume
241.37K
52-wk high
$9.62
52-wk low
$3.53
EPS
-$2.80
Beta
1.24
Shares outstanding
27.60M
No. of employees
67
Open
$6.65
High
$6.87
Low
$6.57
Mkt. cap
184.10M
Avg. vol.
263.68K
Volume
241.37K
52-wk high
$9.62
52-wk low
$3.53
EPS
-$2.80
Beta
1.24
Shares outstanding
27.60M
No. of employees
67
News stories
From web sources and news partners
CarePlus VietNam
·
1 month ago
Precision BioSciences (DTIL) Advances 1.78% as Gene-Editing Speculation Builds - Order Block
Profile
Precision BioSciences, Inc. is a publicly traded American clinical stage gene editing company headquartered in Durham, North Carolina. Founded in 2006, Precision is focused on developing both in vivo and ex vivo gene editing therapies using its proprietary "ARCUS" genome editing platform. Wikipedia
About Precision BioSciences Inc